Your browser doesn't support javascript.
loading
Extended-cycle versus conventional treatment with a combined oral contraceptive containing ethinylestradiol (30 µg) and levonorgestrel (150 µg) in a randomized controlled trial.
Hadji, Peyman; Neulen, Joseph; Schaudig, Katrin; Schwenkhagen, Anneliese; Grimmbacher, Stefanie; Wiegratz, Inka.
  • Hadji P; Frankfurter Hormon-und Osteoporosezentrum, Frankfurt am Main, Germany and Philipps-University of Marburg, Marburg, Germany.
  • Neulen J; Clinic for Gynaecological Endocrinology and Reproductive Medicine, University of Aachen, Aachen, Germany.
  • Schaudig K; Center of Gynaecological Endocrinology, Hormone Hamburg, Hamburg, Germany.
  • Schwenkhagen A; Center of Gynaecological Endocrinology, Hormone Hamburg, Hamburg, Germany.
  • Grimmbacher S; Clinical Science and Operations, Meda Pharma GmbH and Co. KG (A Mylan Company), Bad Homburg, Germany.
  • Wiegratz I; VivaNeo Kinderwunschpraxis Frankfurt, Frankfurt am Main, Germany.
Gynecol Endocrinol ; 36(6): 513-520, 2020 Jun.
Article en En | MEDLINE | ID: mdl-32064971
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Levonorgestrel / Anticonceptivos Orales Combinados / Etinilestradiol / Ciclo Menstrual Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Levonorgestrel / Anticonceptivos Orales Combinados / Etinilestradiol / Ciclo Menstrual Tipo de estudio: Clinical_trials Límite: Adolescent / Adult / Female / Humans País como asunto: Europa Idioma: En Año: 2020 Tipo del documento: Article